Picture of Taisho Pharmaceutical Holdings Co logo

4581 — Taisho Pharmaceutical Holdings Co News Story

0.000.00%
jp flag iconLast trade - 00:00
HealthcareBalancedLarge CapHigh Flyer

Table: Taisho Pharmaceutical HD -2022/23 group results

May 11 (Reuters)- 
          Taisho Pharmaceutical Holdings Co Ltd 
          CONSOLIDATED FINANCIAL HIGHLIGHTS 
     (in billions of yen unless specified)
                   Year ended      Year ended       Year to       NEXT   
                Mar 31, 2023    Mar 31, 2022   Mar 31, 2024     YEAR     
                   LATEST         YEAR-AGO        COMPANY      COMPANY   
                   RESULTS         RESULTS       FORECAST    H1 FORECAST 
  Sales            301.38          268.20         314.50                 
                 (+12.4 pct)     (-4.9 pct)     (+4.4 pct)               
  Operating         23.02           10.74          18.50                 
                (+114.3 pct)     (-46.2 pct)    (-19.6 pct)              
  Recurring         30.44           18.41          22.00                 
                 (+65.3 pct)     (-29.0 pct)    (-27.7 pct)              
  Net
  Net               19.00           13.12          13.00                 
                 (+44.8 pct)     (-1.5 pct)     (-31.6 pct)              
  EPS            231.73 yen      161.12 yen     158.58 yen               
  EPS Diluted    231.43 yen      160.93 yen                              
  Ann Div        100.00 yen      100.00 yen     100.00 yen               
  -Q2 Div         50.00 yen       50.00 yen      50.00 yen               
  -Q4 Div         50.00 yen       50.00 yen      50.00 yen               
  
  NOTE - Taisho Pharmaceutical Holdings Co Ltd.
  *Second Net profit row denotes profit attributable to owners ofthe parent 
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4581.T

Recent news on Taisho Pharmaceutical Holdings Co

See all news